IP Library Granted Patent US 9,730,584
Granted Patent B2
US 9,730,584 · App. 14/176,822 · Granted Aug 15, 2017

Glucose measuring device for use in personal area network

Inventors: Charles L. Nelson (Santa Rosa, CA); Mark Kent Sloan (Redwood City, CA); Robert Y. Jin (Irvine, CA); Feng Jiang (San Ramon, CA); Jen-Chyun Chen (San Jose, CA); Arthur Eugene Anderson, III (Sunnyvale, CA); Charles T. Liamos (Pleasanton, CA)
Assignee: Abbott Diabetes Care Inc.
A61B5/0004A61B5/0017A61B5/0024A61B5/1451A61B5/14532A61B5/18A61B5/742A61B5/7405A61B5/7455G06F19/3418G06Q50/24A61B2562/0295G01N33/66Y10T436/144444
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,730,584
App. No.
14/176,822
Granted
Aug 15, 2017
Kind
B2
Abstract

A glucose measuring system includes a glucose meter that incorporates wireless communication capabilities. The meter can advantageously be a low cost meter by eliminating expensive components, such as the display. The user nevertheless is able to retrieve and view his or her glucose values by referring to displays within the glucose measuring local area network. Feedback via these displays can advantageously be used by the diabetic to create a higher level of confidence and safety.

Claims (27)

1. A data communication system, comprising:

a client unit including a client wireless communication module and a glucose sensor in contact with a bodily fluid to determine a glucose level in the bodily fluid and generate corresponding glucose data, the bodily fluid comprising one of blood or interstitial fluid; and

an automobile including an automobile communication module configured to communicate with the client unit to receive the glucose data from the client unit;

wherein the automobile comprises programming that includes one or more acceptable glucose level ranges, and wherein one or more functions of the automobile is configured to be disabled until the received glucose data is within the one or more acceptable glucose level ranges.

2. The system of claim 1 , wherein the client unit is configured to encrypt the glucose data.

3. The system of claim 2 , wherein the automobile is configured to decrypt the glucose data.

4. The system of claim 1 , wherein the communication between the client unit and the automobile is based on an 802.11 protocol, a short-range wireless communication protocol, a radio frequency (RF) protocol, an infrared data association (IrDA) protocol, or one or more combinations thereof.

5. The system of claim 1 , wherein the automobile is configured to generate one or more health management signals based on the glucose data received from the client unit.

6. The system of claim 1 , wherein the automobile comprises an alarm that is configured to activate based on the received glucose data.

7. The system of claim 6 , wherein the alarm comprises one or more of an audio alert, a graphical display or a vibratory alert.

8. The system of claim 1 , wherein the automobile is configured to provide a suggested action to be taken based on the received glucose data.

9. The system of claim 1 , wherein the automobile is configured to request assistance based on the received glucose data.

10. The system of claim 1 , wherein the automobile programming is configured to request the glucose data from the client unit.

11. The system of claim 10 , wherein the automobile programming is configured to disable one or more functions of the automobile until the glucose data is received.

12. The system of claim 1 , wherein the automobile comprises an interface to receive one or more blood glucose test strips.

13. The system of claim 1 , further including a security code unit including one or more user authorization codes stored in a memory.

14. The system of claim 1 , wherein the client unit is one of a handheld device, a personal digital assistant or a mobile telephone.

15. The system of claim 1 , wherein the automobile is configured to automatically download the glucose data from the client unit when the client unit is located in the automobile.

16. The system of claim 1 , wherein glucose information related to the glucose data is conveyed through an audio system of the automobile.

17. A data communication system, comprising:

a glucose sensor in contact with a bodily fluid and configured to generate one or more signals associated with a monitored glucose level in the bodily fluid including one of blood or interstitial fluid;

a client unit in signal communication with the glucose sensor and configured to process the one or more signals associated with the monitored glucose level from the glucose sensor to generate glucose data; and

an automobile configured to communicate with the client unit to receive the glucose data from the client unit;

wherein the automobile comprises programming where one or more functions of the automobile is configured to be disabled until the received glucose data is within one or more acceptable glucose level ranges.

18. The system of claim 17 , wherein the client unit is one of a handheld device, a personal digital assistant or a mobile telephone.

19. The system of claim 17 , wherein the automobile is configured to automatically download the glucose data from the client unit when the client unit is located in the automobile.

20. The system of claim 17 , wherein the communication between the client unit and the automobile is based on an 802.11 protocol, a short-range wireless communication protocol, a radio frequency (RF) protocol, an infrared data association (IrDA) protocol, or one or more combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2014
From: NELSON, CHARLES L.; SLOAN, MARK K.; JIN, ROBERT Y.; JIANG, FENG; CHEN, JEN-CHYUN; ANDERSON, ARTHUR EUGENE, III; LIAMOS, CHARLES T.; LIMBACH, DOUGLAS C.
To: THERASENSE, INC.
Reel/Frame 033342/0643 →
CHANGE OF NAME Recorded Jul 18, 2014
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 033360/0796 →
Continuity (4)
Continuation 12426887 · Apr 20, 2009
Continuation 10861625 · Jun 4, 2004
Provisional Application 60477730 · Jun 10, 2003
Related Publication 20140155719A1 · Jun 5, 2014